Active substance
IVACAFTOR/TEZACAFTOR/ELEXACAFTOR
Therapeutical formulation
TABLETTEN EN CAPSULES

€ 160.73 € 9,000.99 excluding delivery costs.

This drug is fully reimbursed by your health insurance company.

Conditions apply to the reimbursement of this medicine.

Own risk

€ 160.73 € 9,000.99

This is the amount charged to your deductible per piece per package.

Strength
75/50/100MG
Supplier
ORIGINALIS B.V.
Available outside pharmacies
No
Remarks
  • This medicine is available by prescription only.
  • This drug is imported from {0).Ierland.
EU number
EU/1/20/1468/001

Conditions

Basic insurance

Elexacaftor/Tezacaftor/Ivacaftor Voorwaarde: uitsluitend in combinatie met ivacaftor voor de behandeling van cystische fibrose (CF) patienten van twee jaar en ouder die tenminste een F508del mutatie hebben in het CFTR-gen.